Paraneoplastic neurological syndrome

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
4 Unique IMPs
0 Commercial trials
Drug classes (ATC)
H Endocrinology (ATC H) 1
J Anti-infectives (ATC J) 1
L Oncology (ATC L) 1
V Various (ATC V) 1
Mechanism of action (INN-stem analysis)
Alkylating agent 1 substance
Immunoglobulin 1 substance
Unknown / small molecule 1 substance
Corticosteroid 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Assistance Publique Hopitaux De Paris Academic
    CYCLOPHOSPHAMIDE; HUMAN NORMAL IMMUNOGLOBULIN (IV); MESNA; METHYLPREDNISOLONE HEMISUCCINATE
    2023-506942-22-01 1 country 2025 n=21
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Assistance Publique Hopitaux De Paris Academic 1 Phase II 1
New trials by year
2025
1
← All indication landscapes